Detail akcie 3xL BNSXFRXE/WMA 62 online

Top akcie

Moje portfolio

Nastavit Oblíbené, nastavit Portfolio

Oblíbené tituly

16.02.2026 10:08:57

Indexy online

AD Index online

Region

Výsledková sezóna

3xL BNSXFRXE/WMA 62 (Milan)

Závěr k 13.2.2026	Změna (%)	Změna (EUR)	Objem obchodů (EUR)
80,32	-	-	-

R - Real-Time data si mohou aktivovat klienti Patria Plus / Investor Plus ZDE.

Akce

Popis společnosti

Obecné informace
ISIN	IE00BKT09255

Management společnosti

Funkce	Jméno	Věk	Ve funkci od	Ve firmě od
Chief Executive Officer, Executive Director	Pascal Soriot	66	01.10.2012	01.10.2012
Chief Financial Officer, Executive Director	Aradhana Sarin	-	01.08.2021	01.08.2021
Chief Executive Officer - Alexion, Chief Strategy Officer - AstraZeneca	Marc Dunoyer	72	01.08.2021	01.01.2013
Chief Human Resources Officer, Chief Compliance Officer, General Counsel	Jeffrey Pott	-		01.01.2009
Executive Vice President - BioPharmaceuticals R&D	Sharon Barr	-
Executive Vice President - Global Operations, Information Technology and Chief Sustainability Officer	Pam Cheng	-
Executive Vice President - BioPharmaceuticals Business Unit	Ruud Dobber	60
Executive Vice President - Oncology Business Unit	David Fredrickson	50
Executive Vice President - Oncology and Research and Development	Susan Galbraith	-
Executive Vice President, International	Iskra Reic	-	04.12.2024